Clinical trial
Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and…
NCT00260247 · Odense University Hospital, Other · Completed
Key facts
| NCT number | NCT00260247 |
|---|---|
| Title | Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine. |
| Official title | Induction of Drug Metabolism: A Comparative, Pharmacokinetic in Vivo Study of the Effect of Carbamazepine and Oxcarbazepine on CYP3A4. |
| Lead sponsor | Odense University Hospital, Other |
| Collaborators | Danish Research Agency Novartis Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Clearance Rate |
| Intervention type | Drug |
| Interventions | carbamazepine oxcarbazepine |
| Enrollment | 10 |
| Start date | Apr 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Dec 1, 2005 |
| Last update posted | Apr 22, 2015 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: